Skip to main content
. 2013 Nov 28;4(4):218–227.

Table 2.

Association between common sequence variants in chemokine-related genes and breast cancer risk in postmenopausal women by tumor subtypes

Controls (N=807) Luminal Cases (N=744) Non-luminal Cases (N=73)

Gene Variant Genotype n (%) n (%) OR* (95% CI)* P-value# n (%) OR* (95% CI)* P-value#
CXCR4 0.08 0.75
rs2228014 0.61 (0.39-0.95) 1.28 (0.56-2.93)
CC 689 (92.24) 639 (95.09) 62 (89.86)
TC 56 (7.50) 33 (4.91) 7 (10.14)
TT 2 (0.27) 0 (0.00) 0 (0.00)
rs2680880 1.02 (0.89-1.18) 1.04 (0.74-1.47)
TT 259 (32.33) 243 (32.88) 19 (26.03)
AT 388 (48.44) 341 (46.14) 43 (58.90)
AA 154 (19.23) 155 (20.97) 11 (15.07)
rs2471859 0.91 (0.77-1.07) 0.80 (0.49-1.31)
AA 451 (56.30) 440 (59.54) 45 (61.64)
AG 300 (37.45) 255 (34.51) 26 (35.62)
GG 50 (6.24) 44 (5.95) 2 (2.74)
CCL20 0.22 0.28
rs6749704 0.91 (0.78-1.06) 1.11 (0.77-1.6)
AA 385 (48.06) 380 (51.42) 35 (47.95)
AG 347 (43.32) 299 (40.46) 29 (39.73)
GG 69 (8.61) 60 (8.12) 9 (12.33)
rs940339 1.12 (0.97-1.29) 0.79 (0.55-1.11)
AA 203 (25.37) 181 (24.49) 24 (32.88)
AG 415 (51.88) 356 (48.17) 35 (47.95)
GG 182 (22.75) 202 (27.33) 14 (19.18)
CCR5 0.93 0.77
rs11575816 0.99 (0.86-1.15) 0.95 (0.67-1.35)
GG 318 (39.70) 294 (39.78) 32 (43.84)
AG 376 (46.94) 348 (47.09) 30 (41.1)
AA 107 (13.36) 97 (13.13) 11 (15.07)
CCR6 0.51 1.00
rs3093027 1.22 (0.93-1.60) 1.05 (0.53-2.05)
AA 682 (85.14) 609 (82.52) 62 (84.93)
AC 112 (13.98) 126 (17.07) 11 (15.07)
CC 7 (0.87) 3 (0.41) 0 (0)
rs3093026 0.91 (0.79-1.05) 0.92 (0.65-1.28)
GG 215 (26.84) 210 (28.46) 20 (27.4)
AG 388 (48.44) 369 (50.00) 37 (50.68)
AA 198 (24.72) 159 (21.54) 16 (21.92)
rs3093023 1.05 (0.92-1.21) 1.05 (0.75-1.47)
GG 274 (34.21) 228 (30.85) 22 (30.14)
AG 368 (45.94) 370 (50.07) 38 (52.05)
AA 159 (19.85) 141 (19.08) 13 (17.81)
rs3798315 1.09 (0.87-1.35) 0.86 (0.46-1.61)
GG 639 (79.78) 579 (78.35) 60 (82.19)
AG 150 (18.73) 147 (19.89) 13 (17.81)
AA 12 (1.50) 13 (1.76) 0 (0)
rs3093012 1.02 (0.89-1.18) 0.95 (0.67-1.34)
GG 271 (33.83) 242 (32.75) 26 (35.62)
AG 390 (48.69) 368 (49.80) 35 (47.95)
AA 140 (17.48) 129 (17.46) 12 (16.44)
rs3093010 1.02 (0.88-1.18) 0.91 (0.64-1.31)
CC 365 (45.57) 324 (43.84) 34 (46.58)
AC 336 (41.95) 328 (44.38) 32 (43.84)
AA 100 (12.48) 87 (11.77) 7 (9.59)
rs3093007 0.92 (0.77-1.11) 0.94 (0.57-1.58)
AA 534 (66.67) 510 (69.01) 49 (67.12)
AG 239 (29.84) 203 (27.47) 23 (31.51)
GG 28 (3.50) 26 (3.52) 1 (1.37)
rs3093006 1.04 (0.85-1.29) 1.17 (0.68-2.01)
GG 608 (75.91) 551 (74.56) 53 (72.6)
AG 179 (22.35) 178 (24.09) 18 (24.66)
AA 14 (1.75) 10 (1.35) 2 (2.74)
rs3093005 0.98 (0.59-1.64) 1.04 (0.31-3.51)
AA 768 (96.00) 710 (96.08) 70 (95.89)
AG 32 (4.00) 29 (3.92) 3 (4.11)
GG 0 (0.00) 0 (0.00) 0 (0)
rs11575083 0.89 (0.51-1.55) 1.2 (0.35-4.05)
GG 773 (96.50) 716 (96.89) 70 (95.89)
AG 28 (3.50) 23 (3.11) 3 (4.11)
AA 0 (0.00) 0 (0) 0 (0)
rs3093002 0.90 (0.77-1.05) 1.07 (0.74-1.55)
GG 355 (44.38) 347 (47.02) 33 (47.02)
AG 371 (46.38) 335 (45.39) 31 (42.47)
AA 74 (9.25) 56 (7.59) 9 (12.33)
rs3093001 1.14 (0.99-1.31) 1.00 (0.71-1.4)
AA 208 (26.1) 170 (23.16) 17 (23.29)
AC 399 (50.06) 363 (49.46) 41 (56.16)
CC 190 (23.84) 201 (27.38) 15 (20.55)
rs367523 0.90 (0.77-1.05) 1.15 (0.81-1.63)
CC 303 (37.83) 294 (39.78) 28 (38.36)
CG 392 (48.94) 367 (49.66) 31 (42.47)
GG 106 (13.23) 78 (10.55) 14 (19.18)
rs4710189 0.92 (0.79-1.08) 1.02 (0.71-1.47)
AA 340 (42.45) 329 (44.52) 34 (46.58)
AG 374 (46.69) 340 (46.01) 28 (38.36)
GG 87 (10.86) 70 (9.47) 11 (15.07)
CXCL12 0.69 0.45
rs266093 1.06 (0.91-1.23) 1.07 (0.75-1.54)
GG 299 (40.46) 272 (40.54) 24 (35.29)
GC 338 (45.74) 286 (42.62) 36 (52.94)
CC 102 (13.8) 113 (16.84) 8 (11.76)
rs1029153 0.94 (0.80-1.09) 0.81 (0.56-1.18)
AA 391 (48.81) 370 (50.14) 39 (53.42)
AG 322 (40.2) 299 (40.51) 29 (39.73)
GG 88 (10.99) 69 (9.35) 5 (6.85)
rs1801157 1.03 (0.87-1.24) 1.05 (0.64-1.73)
GG 515 (64.29) 459 (62.11) 46 (63.01)
AG 251 (31.34) 256 (34.64) 25 (34.25)
AA 35 (4.37) 24 (3.25) 2 (2.74)
rs266087 0.91 (0.78-1.06) 1.14 (0.8-1.62)
GG 325 (40.68) 325 (44.04) 24 (32.88)
AG 371 (46.43) 325 (44.04) 41 (56.16)
AA 103 (12.89) 88 (11.92) 8 (10.96)
rs2839695 1.07 (0.90-1.27) 1.25 (0.83-1.88)
AA 504 (62.92) 466 (63.06) 43 (58.9)
AG 270 (33.71) 231 (31.26) 25 (34.25)
GG 27 (3.37) 42 (6.68) 5 (6.85)
rs2236534 1.04 (0.88-1.24) 0.65 (0.38-1.1)
CC 493 (61.55) 456 (61.71) 52 (71.23)
AC 276 (34.46) 242 (32.75) 20 (27.4)
AA 32 (4) 41 (5.55) 1 (1.37)
rs3780891 0.86 (0.68-1.09) 1.2 (0.67-2.15)
GG 647 (80.77) 615 (83.22) 57 (78.08)
AG 144 (17.98) 116 (15.70) 16 (21.92)
AA 10 (1.25) 8 (1.08) 0 (0)
CCL5 0.56 0.63
rs2107538 0.94 (0.78-1.14) 1.12 (0.72-1.73)
GG 541 (67.54) 520 (70.37) 50 (68.49)
AG 240 (29.96) 192 (25.98) 18 (24.66)
AA 20 (2.5) 27 (3.65) 5 (6.85)
CCL3 0.99 0.10
rs9972960 0.99 (0.85-1.15) 1.03 (0.72-1.49)
GG 307 (38.33) 296 (40.05) 25 (34.25)
AG 395 (49.31) 342 (46.28) 41 (56.16)
AA 99 (12.36) 101 (13.67) 7 (9.59)
rs1634502 1.01 (0.87-1.16) 0.71 (0.5-1.01)
AA 286 (35.75) 251 (49.80) 33 (45.21)
AT 372 (46.5) 368 (16.24) 32 (43.84)
TT 142 (17.75) 120 (34.51) 8 (10.96)
CCL4 0.97 0.06
rs10491121 1.00 (0.87-1.15) 0.68 (0.48-0.98)
GG 288 (35.96) 255 (34.51) 33 (45.21)
AG 368 (45.94) 361 (48.85) 33 (45.21)
AA 145 (18.1) 123 (16.64) 7 (9.59)
rs1634517 1.02 (0.86-1.22) 1.57 (1.07-2.32)
CC 472 (59.97) 437 (60.36) 35 (49.3)
AC 282 (35.83) 248 (34.25) 29 (40.85)
AA 33 (4.19) 39 (5.39) 7 (9.86)
rs17679451 1.06 (0.73-1.52) 0.99 (0.41-2.36)
GG 736 (91.89) 676 (91.47) 67 (91.78)
AG 63 (7.87) 61 (8.25) 6 (8.22)
AA 2 (0.25) 2 (0.27) 0 (0)
rs1619526 1.04 (0.88-1.23) 1.39 (0.95-2.05)
GG 472 (58.93) 435 (58.86) 37 (50.68)
AG 292 (36.45) 261 (35.32) 30 (41.1)
AA 37 (4.62) 43 (5.82) 6 (8.22)
*

Odds ratios (ORs) and 95% CI intervals (CI) are adjusted for age.

If genotype counts were less than 5 for any of the three cells, a dominant model was used; otherwise, an additive model was used.

#

P-value adjusted for multiple comparisons within a gene using a P-min permutation test.